Results 181 to 190 of about 1,449,988 (316)

Male-dependent resistance to <i>Spiroplasma</i>-induced cytoplasmic incompatibility. [PDF]

R Soc Open Sci
Pollmann M, Reinisch R, von Berg L, Avidan King M, Geiselmann M, Käppeler LM, Leibson R, Traub N, Steidle JLM, Gottlieb Y.   +9 more
europepmc   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Verticox+: vertically distributed Cox proportional hazards model with improved privacy guarantees. [PDF]

Complex Intell Systems
van Daalen F, Smits D, Ippel L, Dekker A, Bermejo I.   +4 more
europepmc   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

Molecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo, Yoshihiro Mezawa, Zixu Wang, Ahmet Acar, Yasuhiko Ito, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Yataro Daigo, Takuya Shirakihara, Akira Orimo   +11 more
wiley   +1 more source

Arithmetic Proficiency Across Adulthood: Cognitive and Subjective Influences. [PDF]

Eur J Investig Health Psychol Educ
Goettfried E, Thaler K, Delazer M, Basso D, Piazza M, Knoflach M, Zamarian L.   +6 more
europepmc   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington's disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption. [PDF]

Stem Cell Res Ther
Chiu FL, Liang JJ, Lin YL, Kuo HC.
europepmc   +1 more source

Complex Numbers and Physical Reality

, 2001
V.V. Lyahov, V.M. Nechshadim
openalex   +2 more sources

Introducing Complex Numbers into Basic Growth Functions (6) : Hypothetic Breakdown of '1' into Complex Numbers and Application to Definite Integral of exp(t) Expanded into Infinite Series [PDF]

, 2005
Masataka Shimojo, Kentarou Ikeda, Yoki Asano, Reiko Ishiwaka, Hiroyuki Sato, Yutaka Nakano, Manabu Tobisa, Noriko Ohba, Minako Eguchi, Yasuhisa Masuda   +9 more
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source